Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR3 | P49682 | 12/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28809794 | 0.82 | CXCR3 (0.37) | CXCR3KMT2AMAPTMAPK1 | |
| SCHEMBL28947553 | 0.78 | CXCR3 (0.38) | CXCR3KMT2AMAPTMAPK1 | |
| SCHEMBL28947551 | 0.75 | — | — | |
| SCHEMBL27243592 | 0.69 | ALDH1A1 (0.47) | CXCR3KMT2AMAPTMAPK1CYP19A1 | |
| SCHEMBL27320654 | 0.65 | EPHX2 (0.40) | CXCR3KMT2AMAPTMAPK1CYP19A1 | |
| SCHEMBL25425019 | 0.65 | — | — | |
| SCHEMBL12599474 | 0.63 | CXCR3 (0.38) | CXCR3 | |
| SCHEMBL16691957 | 0.61 | EPHX2 (0.38) | CXCR3KMT2AMAPTMAPK1MEN1 | |
| SCHEMBL19882457 | 0.61 | EPHX2 (0.38) | CXCR3KMT2AMAPTMAPK1MEN1 | |
| SCHEMBL457759 | 0.61 | EPHX2 (0.38) | CXCR3KMT2AMAPTMAPK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114746090-A | Azaindole carboxamide compounds for the treatment of mycobacterial infections | 结核病药物开发全球联盟公司 | 2022-07-12 | — | — | CN | disclosed |